Learn More About The History of Ketamine
Since its discovery in 1962, it has been discovered that in sub-anesthetic doses to be a successful treatment of mood disorders including Depression, PTSD, OCD and Anxiety and Chronic Pain Syndromes including Central Sensitization Syndrome, Fibromyalgia, Reflex Simplex Dystrophy.
According to the World Health Organization on May 27th, 2016: updates on Ketamine were presented, in which new potential medical applications were identified. Potential new therapeutic uses were identified, including depression and refractory status epilepticus. The use of Ketamine for treating depression is under evaluation in Phase III clinical studies. Additionally noted in the report, levels of Ketamine abuse appeared to be declining in many countries worldwide.
The US Federal Drug Administration (FDA) has approved Ketamine for both anesthesia and pain control. However, the FDA has not approved ketamine for the treatment of mood disorders or chronic pain alleviation. Therefore, Ketamine infusions for these indications are considered to be an “off label” usage of the medication. Due to this fact, insurance companies and government insurance programs such as Medicaid and Medicare do not pay for these infusions. This is a very safe medication, but like all medications, side effects may occur. To ensure your safety, a physician and a registered nurse will be present and monitor you during the entire course of the infusion.
If you or someone you may know is suffering from a mood disorder or chronic pain, we can help. Contact us today and we will connect you with one of our verified Ketamine Treatment Providers in Pennsylvania for a FREE CONSULTATION.